1. Quantifying attitudes and knowledge change toward animal welfare and sustainability of animal agriculture and the safety and healthfulness of muscle foods. (February 2016) Authors: Carr, C.; Abrams, K.; Velinsky, V.; Eubanks, L.; Johnson, D. Journal: Meat science Issue: Volume 112(2016:Feb.) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model. Issue 1 (23rd March 2016) Authors: Slichter, S. J.; Abrams, K.; Bailey, S. Lawrence; Pellham, E.; Gettinger, I.; Christoffel, T.; Gaur, L.; Latchman, Y.; Nelson, K.; Bolgiano, D. Journal: Vox sanguinis Issue: Volume 111:Issue 1(2016) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0185 Efficacy of Canakinumab in Biologic NaÏVe versus Previously Biologic-Exposed SJIA Patients. (10th June 2014) Authors: Quartier, P.; Grom, A.; Ruperto, N.; Brunner, H.; Schikler, K.; Erguven, M.; Goffin, L.; Hofer, M.; Kallinich, T.; Marzan, K.; Gaillez, C.; Lheritier, K.; Abrams, K.; Martini, A.; Lovell, D. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study. (23rd January 2014) Authors: Quartier, P.; Erguven, M.; Horneff, G.; Berkun, Y.; Lheritier, K.; Kim, D.; Abrams, K.; Constantin, T. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THU0396 Efficacy and safety of canakinumab in patients with TNF receptor associated periodic syndrome (TRAPS). (23rd January 2014) Authors: Gattorno, M.; Obici, L.; Meini, A.; Tormey, V.; Abrams, K.; Davis, N.; Andrews, C.; Lachmann, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0180 Maintenance of Efficacy by Canakinumab Treatment in Systemic Juvenile Idiopathic Arthritis Patients. (10th June 2014) Authors: Wulffraat, N.M.; Ruperto, N.; Brunner, H.I.; Oliveira, S.; Uziel, Y.; Nistala, K.; Cimaz, R.; Ferrandiz, M.A.; Flato, B.; Gamir, M.L.; Koné-Paut, I.; Gaillez, C.; Lheritier, K.; Abrams, K.; Martini, A.; Lovell, D.J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0490 Canakinumab Treatment of Patients with Hyper-IgD Syndrome: An Open-Label, Multicenter, Pilot Study. (23rd January 2014) Authors: Anton, J.; Calvo, I.; Robles, A.; Yagüe, J.; Aróstegui, J.; Viana, R.; Tseng, L.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0306 Subcutaneous secukinumab inhibits radiographic progression in psoriatic arthritis: analysis by prior anti-tnf therapy and concomitant methotrexate use. (12th June 2018) Authors: van der Heijde, D.; Mease, P.; Landewé, R.; Mpofu, S.; Rahman, P.; Tahir, H.; Singhal, A.; Boettcher, E.; Navarra, S.; Zhu, X.; Readie, A.; Pricop, L.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB1089 Investigation of the efficacy and safety of secukinumab treatment in juvenile idiopathic arthritis subtypes of juvenile psoriatic and enthesitis-related arthritis: design of a randomised, double-blind, placebo controlled, multicenter study. (12th June 2018) Authors: Foell, D.; Veit, J.A.; Ilsley, E.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0325 Secukinumab demonstrates a consistent safety profile with up to 5 years treatment in patients with psoriatic arthritis and moderate to severe plaque psoriasis: updated pooled safety analyses. (12th June 2018) Authors: Mease, P.J.; McInnes, I.B.; Reich, K.; Nash, P.; Widmer, A.; Abrams, K.; Pricop, L.; Fox, T. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗